Geneos Wealth Management’s AptarGroup ATR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2K Buy
233
+32
+16% +$3.88K ﹤0.01% 1672
2026
Q1
$25.3K Buy
201
+137
+214% +$17.9K ﹤0.01% 1687
2025
Q4
$7.86K Sell
64
-37
-37% -$4.57K ﹤0.01% 2029
2025
Q3
$13.5K Buy
101
+83
+461% +$12K ﹤0.01% 1864
2025
Q2
$2.82K Buy
18
+13
+260% +$1.96K ﹤0.01% 2735
2025
Q1
$742 Sell
5
-48
-91% -$7.23K ﹤0.01% 2995
2024
Q4
$8.33K Hold
53
– – ﹤0.01% 2120
2024
Q3
$8.49K Buy
53
+13
+33% +$1.93K ﹤0.01% 1895
2024
Q2
$5.63K Buy
+40
New +$5.79K ﹤0.01% 1690
2022
Q1
– Sell
-16
Closed -$1K – 2753
2021
Q4
$1K Buy
+16
New +$1.99K ﹤0.01% 2642

Other funds holding ATR

Geneos Wealth Management's ATR Position: Q2 2026 in Review

Geneos Wealth Management increased its AptarGroup (ATR) stake by 16% in Q2 2026, buying an estimated $3.88K and bringing the position to 233 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Geneos Wealth Management first reported a position in ATR in Q4 2021 and has held it in 10 quarters since. 556 funds tracked by Wall St. Rank hold ATR as of Q2 2026.

  • Geneos Wealth Management held 233 shares of AptarGroup worth $29.2K as of Q2 2026.
  • Geneos Wealth Management bought 32 AptarGroup shares in Q2 2026, an estimated $3.88K.
  • AptarGroup made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1672 holding.
  • Geneos Wealth Management first reported a position in AptarGroup in Q4 2021 and has held it in 10 quarters since.
  • 556 funds tracked by Wall St. Rank held AptarGroup as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.